Grant Yonehiro
Chief Business Officer, Maxygen.
Companies
- Bolt Biotherapeutics, Inc.Chief operating officer Jul 24, 2024 to now1
- Bolt Biotherapeutics, Inc.Chief Business Officer Feb 4, 2021 to Mar 6, 20242
- MaxygenChief Business Officer Mar 4, 2008 to May 18, 20113
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Bolt Biotherapeutics, Inc. BOLT17,269 shares4$72.5K at $4.20Sep 18, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 18, 2026Sold 6,850 shares at $3.24 of Bolt Biotherapeutics, Inc.4
- Sep 17, 2026Sold 4,909 shares at $3.32 of Bolt Biotherapeutics, Inc.4
- Sep 16, 2026Sold 1,417 shares at $3.77 of Bolt Biotherapeutics, Inc.4
- Oct 22, 2025Granted 30,000 shares of Bolt Biotherapeutics, Inc.5
- Dec 6, 2023Bought 2,500 shares at $0.78 of Bolt Biotherapeutics, Inc.6
- Dec 6, 2022Bought 2,500 shares at $1.18 of Bolt Biotherapeutics, Inc.7
- Jun 6, 2022Bought 2,500 shares at $1.64 of Bolt Biotherapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARMaxygen, Chief Business Officer
- 4
- 5SEC EDGARForm 4 filed Oct 24, 2025
- 6SEC EDGARForm 5 filed Feb 6, 2024
- 7SEC EDGARForm 5 filed Feb 7, 2023